|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$97,552.35 |
3.12% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$83,313.54 |
2.66% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$83,061.46 |
2.65% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$80,071.74 |
2.56% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$80,205.51 |
2.56% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$79,866.04 |
2.55% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$74,148.48 |
2.37% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$73,183.23 |
2.34% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$72,905.94 |
2.33% |
| Waters Corporation |
WAT |
941848103 |
184 |
$72,878.72 |
2.33% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$71,409.60 |
2.28% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$71,130.89 |
2.27% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$70,237.68 |
2.24% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$69,701.16 |
2.23% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$69,902.70 |
2.23% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$69,779.76 |
2.23% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$69,442.78 |
2.22% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$67,827.20 |
2.17% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$66,640.50 |
2.13% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$65,549.04 |
2.09% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$65,396.34 |
2.09% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$64,985.84 |
2.08% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$64,665.00 |
2.07% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$62,010.48 |
1.98% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$61,843.32 |
1.98% |
| Steris Plc |
STE |
G8473T100 |
265 |
$61,705.25 |
1.97% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$60,647.73 |
1.94% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$60,381.80 |
1.93% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$60,222.93 |
1.92% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$59,152.91 |
1.89% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$58,911.80 |
1.88% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$58,409.01 |
1.87% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$58,457.04 |
1.87% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$58,271.20 |
1.86% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$57,711.16 |
1.84% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$57,570.12 |
1.84% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$56,699.82 |
1.81% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$54,880.02 |
1.75% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$54,370.92 |
1.74% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$53,655.58 |
1.71% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$53,144.52 |
1.70% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$53,269.20 |
1.70% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$50,046.00 |
1.60% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$49,220.25 |
1.57% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$47,874.46 |
1.53% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$47,360.23 |
1.51% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$46,887.47 |
1.50% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$46,880.95 |
1.50% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$41,749.07 |
1.33% |
| US Dollar |
$USD |
|
14,998 |
$14,997.80 |
0.48% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|